Post-transplant focal segmental glomerulosclerosis refractory to plasmapheresis and rituximab therapy

Nephrol Dial Transplant. 2008 Jan;23(1):425. doi: 10.1093/ndt/gfm616. Epub 2007 Nov 2.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Murine-Derived
  • Female
  • Glomerulosclerosis, Focal Segmental / therapy*
  • Humans
  • Immunologic Factors / therapeutic use*
  • Kidney Transplantation*
  • Middle Aged
  • Plasmapheresis*
  • Postoperative Complications / therapy*
  • Rituximab
  • Treatment Failure

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Immunologic Factors
  • Rituximab